FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281729595> ?p ?o ?g. }

• W4281729595 endingPage "3087" @default.
• W4281729595 startingPage "3072" @default.
• W4281729595 abstract "Repository corticotropin injection (RCI; Acthar® Gel) is approved by the US Food and Drug Administration (FDA) for use in 19 indications, including for the treatment of selected patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), symptomatic sarcoidosis, uveitis, and keratitis. Despite treatment with disease-modifying antirheumatic drugs, many patients with RA, SLE, and other chronic inflammatory rheumatic diseases continue to be affected by severe pain and fatigue, indicating a need for other therapies. To examine the clinical data regarding the impact of RCI treatment on pain and fatigue in selected populations, this review included English-language peer-reviewed publications of clinical trials of any size and cohort studies with more than 10 patients that included pain and/or fatigue based on patient-reported outcomes (PROs) and/or physician-assessed measures in adults following treatment with RCI for RA, SLE, symptomatic sarcoidosis, uveitis, or keratitis. Literature searches identified eight studies that met these criteria. Four studies (reported in five publications) were in patients with RA or SLE, two in patients with sarcoidosis, one in patients with uveitis, and one in patients with noninfectious keratitis. Across the different types of studies assessed (clinical trials, chart reviews, real-world evidence), the results were consistent with respect to the impact of RCI treatment on improving pain and fatigue. As summarized in this review, data from patient- and physician-reported outcome measures in eight studies demonstrate that, in addition to improving more traditional efficacy measures, RCI may also improve pain and fatigue in patients with RA, SLE, symptomatic sarcoidosis, uveitis, and noninfectious keratitis.Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are chronic autoimmune diseases. Clinical studies of drugs for these diseases do not often ask patients how they feel after treatment. Despite treatment, many people with these diseases have pain and feel tired. Repository corticotropin injection (RCI) is a prescription drug for patients with RA, SLE, and other chronic immune diseases. We reviewed the results of published studies with data on pain and fatigue from patients treated with RCI. Four studies were in patients with RA or SLE. Two studies were in patients with symptomatic sarcoidosis. One study was in patients with uveitis. One study was in patients with noninfectious keratitis. These eight studies show that adding RCI to standard treatment lowers pain and fatigue in some patients. It would be helpful to measure pain and fatigue in future clinical studies of drugs for patients with chronic immune diseases." @default.
• W4281729595 created "2022-06-13" @default.
• W4281729595 creator A5007222032 @default.
• W4281729595 creator A5038050644 @default.
• W4281729595 creator A5039081709 @default.
• W4281729595 creator A5048856545 @default.
• W4281729595 creator A5079115002 @default.
• W4281729595 date "2022-05-30" @default.
• W4281729595 modified "2023-10-06" @default.
• W4281729595 title "Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review" @default.
• W4281729595 cites W120325777 @default.
• W4281729595 cites W132722136 @default.
• W4281729595 cites W1423113081 @default.
• W4281729595 cites W1492940207 @default.
• W4281729595 cites W1786220065 @default.
• W4281729595 cites W1905145158 @default.
• W4281729595 cites W1965219244 @default.
• W4281729595 cites W2108189855 @default.
• W4281729595 cites W2137884440 @default.
• W4281729595 cites W2142004396 @default.
• W4281729595 cites W2212944890 @default.
• W4281729595 cites W2510996114 @default.
• W4281729595 cites W2546438361 @default.
• W4281729595 cites W2549786677 @default.
• W4281729595 cites W2600842647 @default.
• W4281729595 cites W2620927456 @default.
• W4281729595 cites W2736683691 @default.
• W4281729595 cites W2740955586 @default.
• W4281729595 cites W2765105454 @default.
• W4281729595 cites W2786441981 @default.
• W4281729595 cites W2905657133 @default.
• W4281729595 cites W2914349717 @default.
• W4281729595 cites W2983166098 @default.
• W4281729595 cites W2986277578 @default.
• W4281729595 cites W3008734483 @default.
• W4281729595 cites W3011220016 @default.
• W4281729595 cites W3033490735 @default.
• W4281729595 cites W3081311626 @default.
• W4281729595 cites W3091166611 @default.
• W4281729595 cites W3124247648 @default.
• W4281729595 cites W3135181020 @default.
• W4281729595 cites W3204748568 @default.
• W4281729595 cites W3207470961 @default.
• W4281729595 cites W3207837208 @default.
• W4281729595 cites W4200135467 @default.
• W4281729595 doi "https://doi.org/10.1007/s12325-022-02176-4" @default.
• W4281729595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35635646" @default.
• W4281729595 hasPublicationYear "2022" @default.
• W4281729595 type Work @default.
• W4281729595 citedByCount "1" @default.
• W4281729595 countsByYear W42817295952023 @default.
• W4281729595 crossrefType "journal-article" @default.
• W4281729595 hasAuthorship W4281729595A5007222032 @default.
• W4281729595 hasAuthorship W4281729595A5038050644 @default.
• W4281729595 hasAuthorship W4281729595A5039081709 @default.
• W4281729595 hasAuthorship W4281729595A5048856545 @default.
• W4281729595 hasAuthorship W4281729595A5079115002 @default.
• W4281729595 hasBestOaLocation W42817295951 @default.
• W4281729595 hasConcept C126322002 @default.
• W4281729595 hasConcept C1862650 @default.
• W4281729595 hasConcept C198451711 @default.
• W4281729595 hasConcept C203014093 @default.
• W4281729595 hasConcept C2776194053 @default.
• W4281729595 hasConcept C2777077863 @default.
• W4281729595 hasConcept C2777575956 @default.
• W4281729595 hasConcept C2777831278 @default.
• W4281729595 hasConcept C2779123688 @default.
• W4281729595 hasConcept C2779134260 @default.
• W4281729595 hasConcept C2781301800 @default.
• W4281729595 hasConcept C3008058167 @default.
• W4281729595 hasConcept C524204448 @default.
• W4281729595 hasConcept C535046627 @default.
• W4281729595 hasConcept C71924100 @default.
• W4281729595 hasConcept C72563966 @default.
• W4281729595 hasConceptScore W4281729595C126322002 @default.
• W4281729595 hasConceptScore W4281729595C1862650 @default.
• W4281729595 hasConceptScore W4281729595C198451711 @default.
• W4281729595 hasConceptScore W4281729595C203014093 @default.
• W4281729595 hasConceptScore W4281729595C2776194053 @default.
• W4281729595 hasConceptScore W4281729595C2777077863 @default.
• W4281729595 hasConceptScore W4281729595C2777575956 @default.
• W4281729595 hasConceptScore W4281729595C2777831278 @default.
• W4281729595 hasConceptScore W4281729595C2779123688 @default.
• W4281729595 hasConceptScore W4281729595C2779134260 @default.
• W4281729595 hasConceptScore W4281729595C2781301800 @default.
• W4281729595 hasConceptScore W4281729595C3008058167 @default.
• W4281729595 hasConceptScore W4281729595C524204448 @default.
• W4281729595 hasConceptScore W4281729595C535046627 @default.
• W4281729595 hasConceptScore W4281729595C71924100 @default.
• W4281729595 hasConceptScore W4281729595C72563966 @default.
• W4281729595 hasFunder F4320315076 @default.
• W4281729595 hasIssue "7" @default.
• W4281729595 hasLocation W42817295951 @default.
• W4281729595 hasLocation W42817295952 @default.
• W4281729595 hasLocation W42817295953 @default.
• W4281729595 hasOpenAccess W4281729595 @default.
• W4281729595 hasPrimaryLocation W42817295951 @default.
• W4281729595 hasRelatedWork W2010260295 @default.

• next